ANALYSIS: Pfizer Is Lobbying The Government For Third Vaccine Doses, And It Could Make Them Billions

Pfizer has helped pave the path for Americans to get a third booster dose of its mRNA COVID-19 vaccine, and the company stands to rake in billions in additional profit if the Food and Drug Administration (FDA) approves a third dose.